Arrestin-3 agonism at D3 dopamine receptors defines a subclass of second generation antipsychotics that promotes drug tolerance

Selin Schamiloglu(University of California, San Francisco), Jennifer L. Whistler(University of California, Davis)
bioRxiv (Cold Spring Harbor Laboratory)
August 18, 2022
Cited by 0


Related Papers